Alert of Recombinant Variant of SARS-CoV-2: Deltacron

Company news
2022-04-01

The current global epidemiology of SARS-CoV-2 is characterized by the worldwide dominance of the Omicron variant. Among the 382,789 sequences uploaded to GISAID with specimens collected in the last 30 days, 381,824 (99.7%) were Omicron, 175 (<0.1%) were Delta, and 649 sequences were not assigned to a Pango lineage (0.2%).

 

Recombinant Variant: Deltacron

 

Recently some recombinant variants were reported in many countries. XD are combinations of Delta and BA.1, or so-called “Deltacron” strains, talked about for months. XD has been present in several European countries. As of 1 April 2022, 5 countries shared 81 genome sequences with unprecedented speed from sample collection to making these data publicly accessible via GISAID EpiCoV, in some cases within less than 24 hours. 

https://www.gisaid.org/hcov19-variants/

 

 

Also, WHO has designated this recombinant variant as Variants under Monitoring (VUM) in Mar 2022. The good news is that, according to the WHO epidemiological update published on 22 March 2022, no new evidence indicates that this recombinant variant assigned XD Pango lineage (Delta-Omicron) is associated with higher transmissibility or severe outcomes.

 

Only information on XD (i.e., GKA (AY.4/BA.1) is found on the GISAID website. Some of the other recombinant variants require further confirmation and investigation. WHO is concerned about “the recent significant reduction in SARS-CoV-2 testing by the several Member States. Data are becoming progressively less representative, less timely, and less robust. This inhibits our collective ability to track where the virus is, how it is spreading and how it is evolving. “

 

We, Bioperfectus, will continue to monitor and closely assess the WHO-reported COVID-19 variants. Our COVID-19 detection products, including SARS-CoV-2 Real-time PCR kits and rapid antigen tests, have been analyzed and show that our performance will not be affected by those variants, including the most prevalent Omicron (including BA.2) and the recent Deltacron. Also, we will keep closely tracking the other recombinant variants. As soon as the complete sequence information is available, we will immediately initiate an analysis of the product's effectiveness against the variants.

 

Download the Letter of Declaration

 

Reference

https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19---29-march-2022

MOST READ

Emergency Release of Bioperfectus Monkeypox Virus Real Time PCR Kit

The recent ongoing monkeypox virus cases outbreak in nonendemic countries caused a series of concerns in public health. As a molecular diagnostic supplier, we are launching Monekypox Virus Real Time PCR Kit as a detection tool to combat the potential spread among people.

2022-05-23

Four Different Dengue Serotypes that Worth Your Attention

Dengue is caused by infection with dengue virus (DENV), a member of the genus Flavivirus, family Flaviviridae.

2022-04-08

Bioperfectus Emergency Response to the Unknown Hepatitis in Children

On 15 April 2022, the World Health Organization (WHO) published an alert on severe acute hepatitis cases of unknown origin in children in the United Kingdom. Since then, there have been continuing additional reports of cases.

2022-05-07